ClinicalTrials.gov
ClinicalTrials.gov Menu

To Determine the Role of Adding Campath-1H or ATG Given In-vivo in Addition to Fludarabine and Low Dose Busulfex on Outcome in Patients Treated With Reduced Intensity Conditioning

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00226512
Recruitment Status : Withdrawn (the PI is no longer work at Hadassah)
First Posted : September 27, 2005
Last Update Posted : April 8, 2011
Sponsor:
Collaborator:
Bayer
Information provided by:
Hadassah Medical Organization

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Primary Completion Date : No date given
  Study Completion Date : No date given